Vice President, Global Market Access, Ophthalmology
Annexon Biosciences
Summary
Build and lead Annexon's global market access strategy for Ophthalmology, shaping the access foundation for the launch and commercialization of Vonaprument, an investigational medicine for patients suffering from Geographic Atrophy. As Vice President, Global Market Access, Ophthalmology, you will define an integrated global approach to pricing, payer engagement, reimbursement, patient services, and distribution, translating that strategy into market-specific access priorities to ensure optimal patient access and sustainable product value. The U.S. will be the first launch market and the primary focus initially, with emphasis on U.S. access strategy, launch readiness, and execution.
Job description
Responsibilities
- Develop and implement a comprehensive global market access strategy, including pricing, reimbursement, and payer engagement, to support the launch and lifecycle management of Vonaprument and future Ophthalmology assets.
- Prioritize the U.S. as the first launch market and primary initial focus, establishing access priorities and readiness plans to support execution.
- Lead cross-functional development of global payer value propositions, access strategies, and evidence plans, incorporating market-specific evidence needs and enabling adaptation for local payer and reimbursement decisions.
- Lead the development of a global pricing strategy and governance framework that reflect the value of Annexon's therapies, balancing market dynamics, payer requirements, patient access, and pricing implications across markets.
- Build and maintain relationships with key payer and reimbursement stakeholders, including government and private insurers, and guide market-specific engagement strategies to secure favorable coverage and reimbursement terms.
- Lead global distribution and channel strategy, guiding market-specific approaches to ensure timely, compliant, and efficient delivery of Ophthalmology products to customers and patients.
- Work closely with Commercial, Medical Affairs, HEOR, Clinical Development, and Regulatory teams to align global market access strategy, evidence generation, and market-level execution with clinical and commercial goals.
- Lead the development of global market access tools, reimbursement support approaches, and payer marketing materials, guiding market-specific adaptation and execution, including patient services, to support launch readiness and patient access.
- Ensure global and market-specific access activities comply with applicable regulations and industry standards, including local pricing and reimbursement policies.
- Build, mentor, and lead a high-performing global market access team; establish clear responsibilities for global strategy and market-level execution while fostering innovation, collaboration, and excellence.
- Evaluate ex-U.S. market access opportunities and requirements to guide decisions on where and when to launch outside the U.S.
- Partner cross-functionally on market prioritization and launch sequencing, and educate internal and external stakeholders on global and market-specific access challenges and opportunities to inform evidence generation and lifecycle decisions.
Education, Experience, and Skills
Required: Bachelor's degree in Business, Health Economics, Public Health, or a related field. 15+ years of experience in market access, pricing, reimbursement, or related roles within the biotech or pharmaceutical industry, with at least 7 years in a leadership role and demonstrated responsibility for global or multi-market access strategy. Demonstrated experience leading market access strategy for product launches in retina and/or Ophthalmology, including translating global strategy into market-specific access and launch plans. Extensive knowledge of U.S. and international market access environments, including payer systems, pricing strategies, reimbursement processes, and differences in evidence requirements across markets. Proven experience in launching and securing market access for IVT products in retina, with the ability to apply that experience to global access strategy and market-specific execution. Strong understanding of health economics and outcomes research (HEOR) and its application to global value propositions, evidence plans, and market-specific access strategies. Excellent strategic thinking and problem-solving abilities. Strong leadership and team management skills, including the ability to build global capabilities and lead across markets and cross-functional teams. Outstanding communication and negotiation skills, with the ability to engage payer and reimbursement stakeholders across markets. Ability to work collaboratively across teams, departments, geographies, and cultures, aligning global priorities with market-specific needs. Proficiency in data analysis and the use of market access tools and technologies.
Preferred: An advanced degree (e.g., MBA, MPH) is strongly preferred.
Requirements
- Bachelor's degree in Business, Health Economics, Public Health, or a related field
- 15+ years of experience in market access, pricing, reimbursement, or related roles within the biotech or pharmaceutical industry
- At least 7 years in a leadership role
- Demonstrated responsibility for global or multi-market access strategy
- Demonstrated experience leading market access strategy for product launches in retina and/or Ophthalmology
- Extensive knowledge of U.S. and international market access environments, including payer systems, pricing strategies, reimbursement processes, and differences in evidence requirements across markets
- Proven experience in launching and securing market access for IVT products in retina
- Strong understanding of health economics and outcomes research (HEOR)
- Excellent strategic thinking and problem-solving abilities
- Strong leadership and team management skills
- Outstanding communication and negotiation skills
- Ability to work collaboratively across teams, departments, geographies, and cultures
- Proficiency in data analysis and the use of market access tools and technologies
- Advanced degree (e.g., MBA, MPH) strongly preferred
Benefits
- Flexible work schedules
- Remote opportunities
- Shuttle service
- Equity participation
- Employee stock purchase plan
- Medical, Dental & Vision
- 401(k)
- Flexible spending plans
Company overview
Annexon Biosciences (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company pioneering a novel approach to treating serious neuroinflammatory diseases by targeting the classical complement pathway. The company's distinctive scientific strategy focuses on inhibiting C1q, the initiating molecule of the classical complement cascade, which when dysregulated can lead to tissue damage and loss in various autoimmune, neurodegenerative, and ophthalmic disorders. Annexon is developing a portfolio of first-in-class therapeutics designed to stop complement-driven inflammation before it starts, addressing unmet medical needs across three therapeutic areas: autoimmunity, neurodegeneration, and ophthalmology. With its lead programs targeting conditions like Guillain-Barré syndrome and geographic atrophy, Annexon employs a biomarker-driven development strategy to advance its pipeline through mid-to-late stage clinical trials. The company's mission is to deliver transformative treatments that enable patients with debilitating neuroinflammatory diseases to live their best lives.